reported that 14, 15-EET induces the occurrence of EMT and cisplatin resistance by activating the FAK/PI3K/AKT pathway, thus the antagonist of 14, 15-EET, 14, 15-EEZE, can reverse EMT and cisplatin resistance in breast cancer (219). Here, AKT1 is linked to breast cancer.